LONDON, Nov. 19, 2008-On 18 November 2008, the US FDA responded to AstraZeneca's Citizen Petition surrounding the company's concern about the approval of any generic version of Pulmicort Respules (budesonide inhalation suspension). While the FDA...
Source: http://www.drugs.com/newdrugs.html
Drugs.com - New Drug Approvals